SOLUTIONS
PROTEOMETER ANTIBODY
IDENTIFICATION &
QUANTIFICATION
Eliminating post-process
steps in T-mAb
production
NOVIPLEX™ PLASMA
COLLECTION SOLUTIONS
Advanced Remote
Plasma Collection
INNOVATION
Learn where leading
Proteomics Research is
headed
ABOUT
Novilytic is a biochemistry analytics company that protects and secures lifesaving drugs and medical devices.
Our potency is extended by our people which includes 5 Ph.D. Chemists and Engineers who have helped us secure significant patents and other IP. Our business plan will increase those forces to insure we meet customer, market, and regulatory demands.
TESTIMONIALS
“The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies.
Eugene L. Inman, Ph.D.
Pharmaceutical Quality Consultant
Retired Eli Lilly and Company
“Novalytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.”
Martin Long, BSc.
Analytical Sciences Business – Past GM
(Brooks Life Sciences, Thermo, Perkin Elmer)
“We couldn’t be more thrilled by the results of our validation and stability analyses using the NoviPlex dry plasma cards and look forward to using them in our DMD clinical trial.”
Ines Macias-Perez, Ph.D
Principle Scientist, Product Development
Cumberland Pharmaceuticals
> 3,000
Global Bioreactors
20 - 50
Proteoforms in Each
One Instrument
Needed
The Proteometer Detects them All!